| Financial Year |
March 31 2023 |
| Monetary Funds |
270,188,406.48 |
| Held-for-trading Financial Assets |
1,685,887.15 |
| Notes Receivable |
-- |
| Accounts Receivable |
172,193,627.17 |
| Advances to Suppliers |
258,047,363.40 |
| Other Receivables |
125,703,734.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
14,059,093.88 |
| Dividend Receivable |
-- |
| Inventories |
134,788,251.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,399,841.06 |
| Total Current Assets |
1,021,007,111.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
888,127.85 |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,437,233,927.04 |
| Fixed Assetes |
78,485,789.00 |
| Under-construction Projects |
49,432,458.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
7,664,436,384.28 |
| Intangible Assets |
5,286,275.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
430,653.11 |
| Deferred Income Tax Assets |
523,684,985.82 |
| Other Non-Current Assets |
45,483,323.61 |
| Sub-Total of Non-Current Assets |
12,103,953,354.64 |
| Total Assets |
13,124,960,465.77 |
| Short-Term Loans |
2,234,969,641.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
43,321,549.84 |
| Accounts Received In Advance |
309,297,729.76 |
| Employee Compensation Payable |
16,081,749.17 |
| Taxes Payable |
239,299,988.69 |
| Interest Payable |
1,459,022,753.23 |
| Dividend Payable |
-- |
| Other payables |
1,628,998,491.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
510,485,302.14 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,982,454,452.21 |
| Long-term Loans |
765,145,453.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,450,051.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,487,635,834.10 |
| Deferred Income Tax Liabilities |
1,970,421,471.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,243,652,810.67 |
| Total Liabilities |
9,226,107,262.88 |
| Paid-In Capital(Or Share Stock) |
2,263,507,518.00 |
| Capital Surplus |
2,577,016,571.85 |
| Surplus Reserve |
49,483,179.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-967,882,563.52 |
| Minority Stockholder's Interest |
199,775,037.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,699,078,165.10 |
| Owner's Equity（Stockholder's Equity） |
3,898,853,202.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,124,960,465.77 |
